drugset

drugset / Trial / NCT04497831

Morphine for Dyspnea in Pulmonary Fibrosis

NCT04497831 ↗

Phase 3 Unknown 20 enrolled Medical University of Gdansk

RandomizedCrossoverDouble-blindTreatment

Summary

"Determination of the effectiveness of nebulized morphine in the treatment of dyspnea in patients with advanced idiopathic pulmonary fibrosis"

Timeline

Start: 2020-09-21
Primary completion: 2022-09-21
Completion: 2022-09-21

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Morphine	Other / unclassified	5 mg	—

Indications